These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3181059)

  • 1. Schizophrenic patients treated with electroconvulsive therapy: their demographic, clinical and cognitive features.
    Gureje O
    East Afr Med J; 1988 Jun; 65(6):379-86. PubMed ID: 3181059
    [No Abstract]   [Full Text] [Related]  

  • 2. Does electroconvulsive therapy (ECT) affect cognitive components of auditory evoked P300?
    Griskova I; Dapsys K; Andruskevicius S; Ruksenas O
    Acta Neurobiol Exp (Wars); 2005; 65(1):73-7. PubMed ID: 15794033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive therapy of schizophrenic patients: problem analysis and empirical results].
    Brenner HD; Hodel B; Kube G; Roder V
    Nervenarzt; 1987 Feb; 58(2):72-83. PubMed ID: 3574559
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy of unilateral ECT.
    Abrams R; DeVito RA
    Dis Nerv Syst; 1969 Apr; 30(4):262-3. PubMed ID: 4890011
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of regressive ECT with process schizophrenia.
    Exner JE; Murillo LG
    Dis Nerv Syst; 1973 Jan; 34(1):44-8. PubMed ID: 4709191
    [No Abstract]   [Full Text] [Related]  

  • 7. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive training of schizophrenic patients. Description of the training and results of a controlled therapeutic study].
    Hermanutz M; Gestrich J
    Nervenarzt; 1987 Feb; 58(2):91-6. PubMed ID: 3574561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity].
    van Waarde JA; Stek ML
    Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1693-7. PubMed ID: 11561488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of predictors of post-ictal delirium after electroconvulsive therapy.
    Kikuchi A; Yasui-Furukori N; Fujii A; Katagai H; Kaneko S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):180-5. PubMed ID: 19335388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral versus bilateral electroconvulsive therapy. Investigations into the therapeutic effect in endogenous depression.
    Strömgren LS
    Acta Psychiatr Scand Suppl; 1973; 240():8-65. PubMed ID: 4515575
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive decline in schizophrenic patients: relationship to other symptoms.
    Dalby JT; Williams R; Dickson R; Yuen O
    J Psychiatry Neurosci; 1994 Nov; 19(5):381-2. PubMed ID: 7803373
    [No Abstract]   [Full Text] [Related]  

  • 16. Present status of unilateral shock treatments.
    Karliner W
    Behav Neuropsychiatry; 1972 Dec-1973 Jan; 4(9-10):2-4. PubMed ID: 4715977
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive side effects of modern ECT: patient experience or objective measurement?
    Vamos M
    J ECT; 2008 Mar; 24(1):18-24. PubMed ID: 18379330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.